- Abstract
3- 10.1016/j.healun.2013.01.399
A Phase One, Open Label, Multi-Dose Study To Evaluate the Safety, Tolerability, and Biologic Effects of Three Doses of IW001 in Patients with Idiopathic Pulmonary Fibrosis (IPF)
- Mar 30, 2013
- The Journal of Heart and Lung Transplantation
- K Rothhaar + 5 more +5
